Neha Kumar, MD - Ophthalmology in Dover, DE

Neha Kumar, MD is a Ophthalmology physician based in Dover, Delaware. Neha Kumar is licensed to practice in Delaware (license number C10010583) and her current practice location is 833 S Governors Ave, Dover, Delaware. She can be reached at her office (for appointments etc.) via phone at (800) 900-2020.

NPI number for Neha Kumar is 1841420478 and her current mailing address is 833 S Governors Ave, Dover, Delaware. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1841420478.

Contact Information

Neha Kumar, MD
833 S Governors Ave,
Dover, DE 19904-4158
(800) 900-2020
(302) 269-3503



Physician's Profile

Full NameNeha Kumar
GenderFemale
SpecialityOphthalmology
Location833 S Governors Ave, Dover, Delaware
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1841420478
  • Provider Enumeration Date: 07/16/2009
  • Last Update Date: 02/02/2017

Medical Identifiers

Medical identifiers for Neha Kumar such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1841420478NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207W00000XOphthalmology C10010583 (Delaware)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Neha Kumar is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Neha Kumar, MD
833 S Governors Ave,
Dover, DE 19904-4158

Ph: (800) 900-2020
Neha Kumar, MD
833 S Governors Ave,
Dover, DE 19904-4158

Ph: (800) 900-2020

News Archive

Low-income groups slow to seek treatment for stroke

People with lower incomes are less likely to present at a hospital within 3 hours of stroke symptoms and thus have lower rates of thrombolysis therapy or post-stroke care than their more affluent counterparts, according to a retrospective analysis.

Fate Therapeutics, BD Biosciences introduce first collaborative iPSC-related product

Fate Therapeutics, Inc. in collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced the introduction of the first induced pluripotent stem cell (iPSC)-related product resulting from the collaboration between the two companies.

New research findings in study of Rett Syndrome

Rudolf Jaenisch of the Whitehead Institute of Biomedical Research in Cambridge, MA reports in the April 6, 2004 online issue of the Proceedings of the National Academy of Sciences that introduction of the MeCP2 protein into post-mitotic nerve cells of MeCP2 mutant mice rescues the symptoms of Rett Syndrome. This raises the possibility that neurons are functionally normal in a newborn child and that neural dysfunction manifests itself only later due to prolonged MeCP2 deficiency. If correct, therapeutic strategies aimed at preventing the onset of Rett symptoms could be initiated at birth.

IU receives NSF awards to lead two high-speed international network services

Indiana University has been awarded $9.2 million from the National Science Foundation to lead two high-speed international network services. The awards provide IU with $4.6 million to continue the TransPAC3 network connection to Asia, and an additional $4.6 million for a new connection to Europe, named ACE - America Connects to Europe.

Scientists identify two markers of inflammation that predict severity of COVID-19 cases

Mount Sinai scientists have identified two markers of inflammation that reliably predict the severity of COVID-19 cases and likelihood of survival, providing a foundation for a diagnostic platform and therapeutic targets, according to a study published in Nature Medicine in August.

Read more News

› Verified 5 days ago


Ophthalmology Doctors in Dover, DE

Dr. Andreas Rauer, M.D.
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 16 Old Rudnick Ln, Dover, DE 19901
Phone: 302-734-1760    Fax: 302-734-1720
Gary I Markowitz, MD
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 833 S Governors Ave, Dover, DE 19904
Phone: 302-674-1121    Fax: 302-674-3891
Dr. David Michael Creech, MD
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 200 Banning St Ste 130, Dover, DE 19904
Phone: 302-678-1700    Fax: 302-678-2330
Dr. Timothy Francis-mooney Doyle, D.O.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 833 S Governors Ave, Dover, DE 19904
Phone: 302-674-1121    Fax: 302-674-3891
Dr. Bryan D. Seiff, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 200 Banning St Ste 370, Dover, DE 19904
Phone: 302-678-3443    Fax: 302-678-9775

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.